Javascript must be enabled to continue!
U-shaped association between plasma sphingosine-1-phosphate levels and mortality in patients with chronic systolic heart failure: A prospective cohort study.
View through CrossRef
Abstract
Background: The endogenous lipid molecule sphingosine-1-phosphate (S1P) has received attention in the cardiovascular field due to its significant cardioprotective effects, as revealed in animal studies. The purpose of our study was to identify the distribution characteristics of S1P in systolic heart failure patients and the prognostic value of S1P for long-term prognosis.
Methods: We recruited 210 chronic systolic heart failure patients from June 2014 to December 2015. Meanwhile 54 healthy people in the same area were selected as controls. Plasma S1P was measured by liquid chromatography-tandem mass spectrometry. Patients were grouped according to the baseline S1P level quartiles, and restricted cubic spline plots described the association between S1P and all-cause death. Cox proportional hazard analysis was used to determine the relationship between category of S1P and all-cause death.
Results: Compared with the control group, the plasma S1P in chronic heart failure patients demonstrated a higher mean level (1.269 μmol/L vs 1.122 μmol/L, P =0.006) and a larger standard deviation (0.441 vs 0.316, P =0.022). Based on multivariable Cox regression with restricted cubic spline analysis, a non-linear and U-shaped association between S1P levels and the risk of all-cause death was observed. After a follow-up period of 31.7 ± 10.3 months, the second quartile (0.967-1.192μml/L) with largely normal S1P levels had the lowest all-cause mortality and either an increase (adjusted HR=2.368, 95%CI 1.006-5.572, P =0.048) or a decrease (adjusted HR=0.041, 95%CI 0.002-0.808, P =0.036) predicted a worse prognosis.The survival curves showed that patients in the lowest quartile and highest quartile were at a higher risk of death.
Conclusions: Plasma S1P levels in systolic heart failure patients are related to the long-term all-cause mortality with a U-shaped correlation.
Springer Science and Business Media LLC
Title: U-shaped association between plasma sphingosine-1-phosphate levels and mortality in patients with chronic systolic heart failure: A prospective cohort study.
Description:
Abstract
Background: The endogenous lipid molecule sphingosine-1-phosphate (S1P) has received attention in the cardiovascular field due to its significant cardioprotective effects, as revealed in animal studies.
The purpose of our study was to identify the distribution characteristics of S1P in systolic heart failure patients and the prognostic value of S1P for long-term prognosis.
Methods: We recruited 210 chronic systolic heart failure patients from June 2014 to December 2015.
Meanwhile 54 healthy people in the same area were selected as controls.
Plasma S1P was measured by liquid chromatography-tandem mass spectrometry.
Patients were grouped according to the baseline S1P level quartiles, and restricted cubic spline plots described the association between S1P and all-cause death.
Cox proportional hazard analysis was used to determine the relationship between category of S1P and all-cause death.
Results: Compared with the control group, the plasma S1P in chronic heart failure patients demonstrated a higher mean level (1.
269 μmol/L vs 1.
122 μmol/L, P =0.
006) and a larger standard deviation (0.
441 vs 0.
316, P =0.
022).
Based on multivariable Cox regression with restricted cubic spline analysis, a non-linear and U-shaped association between S1P levels and the risk of all-cause death was observed.
After a follow-up period of 31.
7 ± 10.
3 months, the second quartile (0.
967-1.
192μml/L) with largely normal S1P levels had the lowest all-cause mortality and either an increase (adjusted HR=2.
368, 95%CI 1.
006-5.
572, P =0.
048) or a decrease (adjusted HR=0.
041, 95%CI 0.
002-0.
808, P =0.
036) predicted a worse prognosis.
The survival curves showed that patients in the lowest quartile and highest quartile were at a higher risk of death.
Conclusions: Plasma S1P levels in systolic heart failure patients are related to the long-term all-cause mortality with a U-shaped correlation.
Related Results
U-shaped association between plasma sphingosine-1-phosphate levels and mortality in patients with chronic systolic heart failure: A prospective cohort study.
U-shaped association between plasma sphingosine-1-phosphate levels and mortality in patients with chronic systolic heart failure: A prospective cohort study.
Abstract
Background: The endogenous lipid molecule sphingosine-1-phosphate (S1P) has received attention in the cardiovascular field due to its significant cardioprotective ...
Magnetohydrodynamics enhanced radio blackout mitigation system for spacecraft during planetary entries
Magnetohydrodynamics enhanced radio blackout mitigation system for spacecraft during planetary entries
(English) Spacecraft entering planetary atmospheres are enveloped by a plasma layer with high levels of ionization, caused by the extreme temperatures in the shock layer. The charg...
Clinical predictors of post–liver transplant new-onset heart failure
Clinical predictors of post–liver transplant new-onset heart failure
Objectives of this study were (1) to evaluate preoperative predictors of systolic and diastolic heart failure in patients undergoing liver transplantation (LT) and (2) to describe ...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Novel phosphate-based cements for clinical applications
Novel phosphate-based cements for clinical applications
This Thesis aims at the development of two novel families of inorganic phosphate cements with suitable characteristics for clinical applications in hard tissue regeneration or repl...
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
Cardiovascular diseases (CVDs) are the fastest-growing cause of death around the world, and atherosclerosis plays a major role in the etiology of CVDs. The most recent figures show...
Treatment outcomes and associated factors among chronic ambulatory heart failure patients at Jimma Medical Center, South West Ethiopia: prospective observational study
Treatment outcomes and associated factors among chronic ambulatory heart failure patients at Jimma Medical Center, South West Ethiopia: prospective observational study
Abstract
Background
Heart failure has been one of the major causes of hospitalization across the world. Focusing on the treatment outcomes of ambula...

